Xylem Q3 Adj. EPS $0.99 Beats $0.89 Estimate, Sales $2.08B Beat $1.99B Estimate
Portfolio Pulse from Benzinga Newsdesk
Xylem (NYSE:XYL) reported Q3 earnings of $0.99 per share, beating the analyst consensus estimate of $0.89 by 11.24%. This is a 13.79% increase from the same period last year. The company also reported quarterly sales of $2.08 billion, beating the analyst consensus estimate of $1.99 billion by 4.32%. This is a 50.43% increase from the same period last year.
October 31, 2023 | 10:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xylem's Q3 earnings and sales exceeded analyst estimates, indicating a strong financial performance. This could potentially lead to a positive impact on the company's stock price in the short term.
Xylem's Q3 earnings and sales have surpassed analyst estimates, which is typically a positive signal for investors and can lead to an increase in the stock price. The significant YoY growth in earnings and sales further strengthens this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100